New glucose sensors and a partnership with Abbott are expected to drive sales growth at MiniMed, BTIG analyst Marie Thibault ...

Years after being absorbed by Medtronic, Northridge-based MiniMed Group has spun off on its own again and went through an IPO. Chief Executive Que Dallara at the ribbon cutting ceremony for MiniMed in ...

Analysts are bullish on MiniMed’s potential following the company’s recent spinout from Medtronic. In a report issued Tuesday, Marie Thibault, a BTIG analyst, noted that MiniMed has the scale, reach, ...

Investing.com - William Blair initiated coverage on MiniMed Group (NASDAQ:MMED) with an Outperform rating. The firm notes MiniMed is a diabetes devices company with a product portfolio spanning ...

Investing.com - Mizuho initiated coverage on MiniMed Group (NASDAQ:MMED) with an outperform rating and set a price target of $21.00, representing roughly 46% upside from the current stock price of $14 ...

MiniMed (MMED) Wednesday announced U.S. Food and Drug Administration (FDA) clearance of MiniMed Flex, a next-generation discreet, smartphone-controlled insulin pump. About half the size of the MiniMed ...

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Wondering if Minimed Group at around US$14.01 is pricing in ...

Investing.com - Piper Sandler initiated coverage on MiniMed Group (NASDAQ:MMED) with a Neutral rating and a price target of $16.00. The stock currently trades at $14.35, near its 52-week low of $14.10 ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MiniMed (MNMD) shares gained for the first time in five sessions on Tuesday as Medtronic’s (MDT) diabetes business received multiple bullish views on Wall Street as its post-IPO quiet period ended.

Medtronic plc (NYSE:MDT) is included among the 15 Best Consistent Dividend Stocks to Buy Right Now. On April 6, Stifel lowered its price recommendation on Medtronic plc (NYSE:MDT) to $95 from $105. It ...